BG Medicine, Inc. (BGMD)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2015 | -5.3 Million USD | 34.24% |
| 2014 | -8.06 Million USD | 49.12% |
| 2013 | -15.84 Million USD | 33.32% |
| 2012 | -23.76 Million USD | -35.19% |
| 2011 | -17.58 Million USD | -2.45% |
| 2010 | -17.16 Million USD | -6.35% |
| 2009 | -16.13 Million USD | -7.05% |
| 2008 | -15.07 Million USD | 0.0% |
| 2006 | -4.74 Million USD | 42.4% |
| 2005 | -8.23 Million USD | -218.7% |
| 2004 | -2.58 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2015 FY | -5.3 Million USD | 34.24% |
| 2015 Q3 | -1.02 Million USD | 49.58% |
| 2015 Q4 | -902 Thousand USD | 11.83% |
| 2015 Q1 | -1.34 Million USD | -2.2% |
| 2015 Q2 | -2.02 Million USD | -50.52% |
| 2014 Q1 | -2.17 Million USD | -12.61% |
| 2014 FY | -8.06 Million USD | 49.12% |
| 2014 Q3 | -2.39 Million USD | -10.51% |
| 2014 Q4 | -1.31 Million USD | 44.97% |
| 2014 Q2 | -2.16 Million USD | 0.46% |
| 2013 Q3 | -3.66 Million USD | 24.23% |
| 2013 FY | -15.84 Million USD | 33.32% |
| 2013 Q2 | -4.83 Million USD | 10.62% |
| 2013 Q1 | -5.41 Million USD | -86.69% |
| 2013 Q4 | -1.93 Million USD | 47.2% |
| 2012 Q3 | -6.81 Million USD | -6.59% |
| 2012 Q2 | -6.39 Million USD | 16.57% |
| 2012 Q1 | -7.66 Million USD | -61.87% |
| 2012 FY | -23.76 Million USD | -35.19% |
| 2012 Q4 | -2.89 Million USD | 57.46% |
| 2011 Q4 | -4.73 Million USD | 3.01% |
| 2011 Q1 | -3.13 Million USD | 5.78% |
| 2011 Q2 | -4.83 Million USD | -54.46% |
| 2011 FY | -17.58 Million USD | -2.45% |
| 2011 Q3 | -4.88 Million USD | -0.93% |
| 2010 Q4 | -3.32 Million USD | 25.94% |
| 2010 FY | -17.16 Million USD | -6.35% |
| 2010 Q3 | -4.48 Million USD | -19.91% |
| 2010 Q2 | -3.74 Million USD | 33.3% |
| 2010 Q1 | -5.61 Million USD | -32.41% |
| 2009 Q4 | -4.23 Million USD | 3.64% |
| 2009 FY | -16.13 Million USD | -7.05% |
| 2009 Q3 | -4.39 Million USD | 0.0% |
| 2008 FY | -15.07 Million USD | 0.0% |
| 2007 Q3 | -2.17 Million USD | -7.34% |
| 2007 Q2 | -2.03 Million USD | -32.08% |
| 2007 Q1 | -1.53 Million USD | -5389.29% |
| 2006 FY | -4.74 Million USD | 42.4% |
| 2006 Q3 | -1.26 Million USD | 2.31% |
| 2006 Q1 | -2.15 Million USD | 0.0% |
| 2006 Q2 | -1.29 Million USD | 39.67% |
| 2006 Q4 | -28 Thousand USD | 97.79% |
| 2005 FY | -8.23 Million USD | -218.7% |
| 2004 FY | -2.58 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 100.0% |
| Ansell Limited | 76.5 Million USD | 100.0% |
| Ansell Limited | 76.5 Million USD | 100.0% |
| Biotage AB (publ) | 24.28 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | -1.63 Million USD | 100.0% |
| Psykey, Inc. | -1.32 Million USD | 100.0% |
| ConvaTec Group Plc | 130.3 Million USD | 100.0% |
| ConvaTec Group Plc | 130.3 Million USD | 100.0% |
| Encision Inc. | -691.78 Thousand USD | 100.0% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 100.0% |
| Innovative MedTech Inc. | -7.93 Million USD | 100.0% |
| LifePoint, Inc. | -15.23 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | -274.44 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | -86.4 Million USD | 100.0% |
| Sector 10, Inc. | 7036.00 USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.0% |
| SheerVision, Inc. | -71.37 Thousand USD | 100.0% |
| United Health Products, Inc. | -2.62 Million USD | 100.0% |
| Vasamed, Inc. | -4.88 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 100.0% |
| Yubo International Biotech Limited | -1.2 Million USD | 100.0% |